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In-stent Restenosis after Carotid Angioplasty and Stenting: Post-
Carotid Endarterectomy Lesions Fare Equally as Well as True De Novo
Lesions
Christopher L Stout1, Albert I Richardson, II1, Susanna H Shin2, Rasesh M
Shah1, Jean M Panneton1. 1Division of Vascular Surgery, Eastern Virginia
Medical School, Norfolk, VA; 2Department of General Surgery, Eastern
Virginia Medical School, Norfolk, VA
Objectives: Restenosis following carotid endarterectomy (CEA) can
be treated with carotid angioplasty and stenting (CAS), but concerns about
durability exist. Data for CAS restenosis following CEA is limited and
conflicting and includes arteries that have been radiated. The disease process
of radiated arterial restenosis is different. We compare the long-term results
of CAS performed after ipsilateral CEA to results of CAS for true de novo
carotid stenosis.
Methods: 269 consecutive CAS procedures between January 2003 and
August 2008 were performed on 254 patients. 18 patients were excluded for
neck radiation therapy to represent true de novo lesions for comparison.
Seventy four procedures were performed for post-CEA indication and 173
procedures for de novo lesions. Standard statistical analysis was used. In-
stent restenosis was defined as  50% stenosis using duplex ultrasound
internal carotid artery peak systolic velocity 220 centimeters per second
(cm/s) and internal to common carotid artery peak systolic velocity ratio
2.7.
Results:Mean age was 73 years (range: 43.7-90.4). 55%weremale and
45% female. Caucasians comprised 90% and African-Americans 8%. Mean
follow-up was 13.1 months (range, 0-63.4). Demographic information and
risk factors were similar except for age (73.8 years de novo versus 71.1 years
post-CEA; p0.035), smoking (62% post-CEA versus 42% de novo;
p0.004), symptomatic (27% post-CEA versus 45% de novo; p0.008),
and embolic protection use (92% post-CEA versus 99% de novo; p0.001).
Overall, 30-day risk of stroke was 3.2%, death was 1.2%, and myocardial
infarction was 0.8% with no group differences (p0.273, p0.53, and
p0.16, respectively. Three year overall survival was not significant: de novo
group at 75% compared to 53% for post-CEA group (p0.074). At four years
the overall freedom from stroke was 96% with no group difference (p0.19).
Primary patency at three years was similar, 89% for post-CEA and 91% for the de
novo group (p0.211).Only 3 patients (pNS) had duplex ultrasound criteria
indicative of80% stenosis, none required reintervention.
Conclusion: There is not an increased rate of in-stent restenosis
following CAS for post-CEA restenosis compared to non-radiated true de
novo lesions.
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Radial Force of Carotid Stents: Uncovered Ground With Potential
Clinical Consequences
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M T Pattynama1, Bart E Muhs2, Hence J M Verhagen1. 1Erasmus Medical
Centre, Rotterdam, Netherlands; 2Yale New Haven Hospital, New Haven,
CT
Objective: Carotid angioplasty and stenting (CAS) is an increasingly
performed alternative to carotid endarterectomy. Complications include
hypoperfusion of the brain as a result of overstimulation of the barorecep-
tors, by balloon dilatation or by the radial force of the stent. In this study we
tested the radial force of four different carotid stents. Two open cell nitinol
stents (Acculink® and Protégé®), one hybrid nitinol stent (Cristallo Ideale®)
and a braided elgiloy stent (Wallstent®).
Methods: Five stents of each type were deployed in three loops of
bopet film. These films were attached to aluminium rods with copper strain
gauges, forming a half Wheatstone bridge. The radial force of the stent leads
to pulling of the rods and voltage differences in the strain gauges which can
be precisely and reliably measured. We performed two tests, one of stent
deployment and one simulation of a clinically relevant stenosis.
Results: In stent deployment, the Protégé® produced a peak radial
force of 62cN, the Wallstent® 38cN, the Acculink® 35cN and the Cristallo
Ideale® 15cN (p0,05). In the simulated stenosis (figure 1) the Protégé®
had the greatest peak radial force of 328cN and theWallstent® produced the
lowest radial force of 84 cN (p0,05).
Conclusions: Radial forces exerted by carotid stents vary significantly
between various stent designs. In both tests the Protégé® stent generates a
radial force far greater than all the other stents. Clinical results of CAS may
be very dependent of the specific stent used and may therefor not be
generalized for all carotid stent systems.In our opinion, besides flexibility
and free cell area, an objective comparison of radial force is necessary for a
well-considered choice of stent type in the individual patient.Author Disclosures: M.T. Voûte, None; J.M. Hendriks, None; J.H.H.
Van Laanen, None; P.M.T. Pattynama, None; B.E. Muhs, None;
H.J.M. Verhagen, None.
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Carotid Stenting (CAS) Vs. Carotid Endarterectomy (CEA): Patients
Choice?
Kenneth Granke1, Brenada Allende1, Micheal Bojalian1, Angelikea Vouy-
ouka2, Jacob Gordon1, John Malleis1. 1Wayne State Medical School, De-
troit, MI; 2Mt Sinai Hospital, New York, NY
Introduction: Trials on CAS, typically in high risk patients, suggest a
1% higher stroke rate but show equivalency to CEA. Unfortunately, the
CEA results usually exceed the accepted limits of proven benefit set in ACAS
andNACET. To assess benefit at one institution, patients were prospectively
offered their choice of CAS or CEA, regardless of risk status.
Methods: Between October 2002 and May 2007, with IRB approval,
consecutive patients at a VA hospital were analyzed after they selected either
CAS or CEA. They were informed of a possible 1% greater risk of stroke with
CAS. A single Neurologist (JG) verified neurological exams. Variables
compared: age, beta-blocker use, diabetes (DM), hypertension (HTN),
coronary artery disease (CAD), respiratory disease (RD), intermittent clau-
dication (IC), stroke, TIA, amaurosis fugax, operative room time, transfu-
sion, length of stay (LOS), myocardial infarction, nerve injury, hematoma,
stroke and death. Statistical analysis was performed using Fischer’s Exact and
Mann-Whitney Tests.
Results: 92 patients underwent 98 procedures (48 CEA /50 CAS).
Although 75% were high risk, there were no differences in high/low risk,
asymptomatic/symptomatic patient choice of CAS vs. CEA, nor between:
age, HTN, DM, CAD, IC. The CEA group had a higher incidence of RD
(p0.015), TIA (P0.008) and smoking (P0.002). Operative time was
higher in CEA vs. CAS (2.1 hr. vs. 1.3 hr; P0.02). There was no difference
in LOS or transfusion. CEA had higher major complications: MI (2 vs. 0%),
nerve injury (4 vs. 0%) and hematoma (11 vs. 3%) compared to CAS
(p0.01). The 30 day stroke/mortality rates were no different: 0/2% and
2.1/0 % for CEA and CAS, respectively. Mean follow-up was 27.2 vs. 22.8
months for CEA vs. CAS, respectively with no late neurological symptoms
and similar deaths. One restenosis in each group was treated with CAS. Four
patients had contra lateral treatments (3 CEA underwent CAS and 1 CAS
underwent CEA).
Conclusion: When both surgical and endovascular treatment out-
comes are within established standards, pre-operative risk status need not be
the factor for recommending CAS. Consideration should be given to
in-dividual and /or institutional perioperative outcomes to guide reimburse-
ment recommendations to allow the patient a choice between CEA and
CAS.
Author Disclosures: K. Granke, speaker, king pharmaceuticals; B. Al-
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Transcranial Doppler Monitoring is Vital in Thoracic Endograft Place-
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ceptable treatment alternative to open surgical repairs. It has been shown
that risk factors for developing a stroke during TAG are obesity, blood loss
and vascular embolization. Manipulation of the aortic arch during cardiac
catheterization has likewise been identified as a source of cerebral emboliza-
tion. The influences of endograft placement on cerebral embolization and
flow is not well described. As such, our aim is to quantify the number of
microembolic signals (MES,) velocities (VEL), and pulsatility index (PI)
detected by Transcranial Doppler (TCD) during different stages of the
endograft placement and correlate them with landing zones, subclavian
revascularization and number of devices used.
Methods: Twenty (20) patients were monitored with TCD during
endovascular repair of the thoracic aorta. Imaging and medical parameters
were entered into a combined database. We recorded middle cerebral artery
(MCA) velocities, pulsatility index (PI) and embolic count.
Results: TCD monitoring was successful in all patients. The highest
MES counts were generated by the pig tail catheter during the diagnostic
stage (DS) and by device placement during deployment phase (DP). Em-
bolic count to right/left (Rt/Lt) sides were the same overall. In DS an
average of 8.65 MES were seen Rt/Lt, while during DP 45.40 and 42.68
MES were seen respectively for Rt and Lt. Baseline MCA velocities were
similar for Rt and Lt and increased significantly from baseline during balloon
inflation from (Rt. 33.5 to 50.2 p-value 0.02; Lt 32.5 to 47.2 p-value
0.001). Similarly, the pulsatility index increased from 0.95 (Rt) and 1.02
(Lt) to 1.43 (Rt) and 1.38 (Lt) (p-value 0.0005 and 0.0009 respectively for
Rt and Lt). There was no correlation between post-operative stroke TIA,
arch type, landing zone or coverage of the subclavian artery and number of
MES.
Conclusions: The ability of TCD to detect cerebral emboli and alter-
ations in flow patterns is important to reveal which steps of thoracic en-
dografting are most likely to provoke emboli and hymodynamic changes. It
also has a potential to compare endografts and their capacity to generate
emboli.
Author Disclosures: J. Bismuth, None; Z. Garami, None; H.K. Younes,
None; P. Harris, None; J. Naoum, None; M. Davies, None; E. Peden,
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The Effect of Ethnicity and Insurance Type in the Early Adoption of
Thoracic Endovascular Repair (TEVAR)
Frank R Arko, III, Erin H Murphy, Charles M Davis, Stephen T Smith, J
Gregory Modrall, G Patrick Clagett. University of Texas Southwestern
Medical Center, Dallas, TX
Background:Mortality and complication rates for open thoracic aortic
aneurysm repair have declined but still remain high. Recently with the
introduction of TEVAR morbidity and mortality have improved, but in a
large general population are unknown. The purpose of this study is to
determine the influence of ethnicity and insurance type on procedure
selection and outcome following TEVAR.
Methods: Using the Nationwide Inpatient Sample (NIS) database
ethnicity and insurance type were evaluated against the outcome variables of
mortality and complications associated with thoracic aneurysm repair.
Results: Between 2001-2005, a total of 875 patients undergoing
TEVAR were analyzed with a significantly greater proportion of Caucasians
over African Americans and Hispanics (650, 104, and 49, respectively) with
72 patients categorized as other. The majority of subjects in all races were
male and most of the procedures were elective. The overall mortality was
13.3% (n117) and spinal cord ischemia was 0.8% (n7) with no difference
between ethnicity and insurance type. Significant differences were notable in
all demographic characteristics among races including gender (p0.003),
income (p0.0001), hospital region of surgery (p0.001), hospital bed size
(p0.013), and insurance type (p0.001). Variations in demographic
characteristics were also present in the univariate analysis associated with
insurance classifications with significant differences in gender (p0.001),
surgery type (p0.009), income (p0.003), race p0.0001) and comor-
bidity index (p0.0001). Bivariate analysis by race resulted in few statisti-
cally significant differences except for infection (p0.007) and other com-
plications (p0.003) with African Americans and Hispanics having a higher
incidence respectively. Bivariate comparison by insurance resulted in a
greater number of significant differences including nonroutine discharge
(p0.009), intestinal ischemia (p0.039), and transfusions (p0.003).
Conclusions: There is a significant difference in ethnicity in the repair
of thoracic aneurysms but no difference in mortality among groups. The
incidence of spinal cord ischemia is very low with no difference between
groups. Ethnicity and type of insurance is associated with a higher risk of
complications with TEVAR.
Author Disclosures: F.R. Arko, None; E.H. Murphy, None; C.M.
Davis, None; S.T. Smith, None; J.G. Modrall, None; G.P. Clagett,
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TEVAR in Female Patients: Increased Aortic Coverage is Associated
with a Higher Risk of Spinal Cord Ischemia
Tejas R. Shah, StephenMBauer, Neal S Cayne, ThomasMaldonado, Caron
Rockman. New York University Medical Center, New York, NY
Background: There is a paucity of literature regarding thoracic endo-
vascular aneurysm repair (TEVAR) in women. We report our institutional
experience with TEVAR in women.
Methods: A retrospective chart review was performed. Case planning
was done with CTa. Patients with small access vessels received a 10mm
common iliac artery (CIA) conduit. Patients received a CTa 30-days post-
operatively. Post-operative stroke was diagnosed clinically and by cerebral
imaging. Spinal cord ischemia (SCI) was diagnosed clinically with negative
cerebral imaging.
Results: TEVAR was performed in 51 patients for a variety of aortic
pathologies; of these 29 (56%) were female. The mean age of women was
73.5 years. Mean TAA diameter was larger for women than for men (5.9 cm
vs. 4.7 cm). TEVARwas performedmore often on an urgent basis in women
as compared to men (20.7% vs. 9.5%, p NS). There was a trend towards
pain as the predominant presenting symptom in women as compared tomen
(44.8% vs. 22.7%, p NS). There was a statistically significant difference in
the need for a CIA conduit in women compared to men (48.3% vs. 20.0%,
p0.05). This was not associated with an increase in peripheral ischemic
complications or an increase length of stay (LOS). There were no differences
in endoleak rate, stroke, or post-operative death. Although not statistically
significant, there was a concerning trend towards an increase in paraplegia in
women, 10.3% versus 4.8%. This may be related to the statistically significant
increase in the total length of aortic coverage required in women compared
to men, 18.2 cm versus 15.2 cm (p0.05).
Conclusion: Our data suggests that TEVAR in women is safe and
effective. Women presented more frequently with indications for urgent
intervention. As expected, women require a conduit more often due to
smaller access vessel size, but this does not increase the rate of peripheral
ischemic complications or LOS. The length of aortic coverage is greater in
women than in men, and this may be related to their being treated for larger
aneurysms and more advanced or diffuse disease. The increase in length of
coverage appears to be associated with a concerning increase in postopera-
tive paraplegia. Female patients undergoing TEVAR should be considered
for prophylactic maneuvers to prevent SCI, including minimizing length of
coverage.
Author Disclosures: T.R. Shah, None; S.M. Bauer, None; N.S. Cayne,
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Carotid Angioplasty and Stenting: Treatment of Post CEA Restenosis
is at Least as Safe as Primary Stenosis Treatment
Jan Albert Vos1, Gert J De Borst2, Tim Th C Overtoom1, Jean Paul P M de
Vries1, Eric DW van de Pavoordt3, Pieter Zanen2, Rob G A Ackerstaff3. 1St
Antonius Hospital, Nieuwegein, Netherlands; 2University Medical Center
Utrecht, Utrecht, Netherlands; 3St Antonius Ziekenhuis, Nieuwegein,
Netherlands
Objectives: To compare Transcranial Doppler (TCD) and outcome of
Carotid Angioplasty and Stenting (CAS) in post Carotid Endarterectomy
(CEA) restenoses versus primary atherosclerotic stenoses.
Design: Retrospective analysis of prospectively accumulated database.
Material and Methods: 812 CAS procedures were divided into two
groups: group 1: 72 restenoses; group 2: 740 primary stenoses. Clinical
endpoints: cerebral ischemic events and death. TCD endpoints: numbers of
isolated micro emboli and micro embolic showers, during five procedural
phases. Mann-Whitney U test and 
2-test were used. To test for indepen-
dence of variables the Mantel-Haentzel test and univariate regression anal-
ysis were performed. P.05 was regarded as statistically significant.
Results: Groups were evenly matched for demographic data (median
age: 70 vs. 71 years, male: 44/72 [61%] vs. 525/740 [71%], symptomatic
14/72 [19%] vs. 147/740 [20%]). There were 7 fatalities (0.9 %), 10 major
(1.2%) and 21 minor (2.6%) strokes, all occurred in group 2 (P0.049),
which was independent from CPD use. After correction for the difference in
CPDuse between groups (17/72 [24%] vs. 345/740 [47%]), no statistically
significant differences were found in numbers of isolated emboli and embolic
showers in any of the procedural phases, nor for the entire procedure. No
statistically significant differences were found for TCD data between early
and late restenoses analysing 2 and 3 years as cut off points.
Conclusions: CAS for restenosis after CEA has a complication rate
lower than primary CAS; time interval between CEA and CAS did not
influence micro embolic load.
